Advances and critical evaluation of autonomous protein engineering: towards transparent, accessible, and reproducible platforms

Protein engineering aims to enhance enzymatic properties such as activity, selectivity, stability, and solvent tolerance by restructuring protein frameworks beyond natural performance limits. This process relies on the iterative Design-Build-Test-Learn cycle, where experimental feedback guides progressive improvements. Advancements in artificial intelligence have transformed both the Design and Learn phases, with zero-shot protein language models predicting beneficial mutations directly from sequence data and supervised models integrating assay results to refine subsequent variant designs. These approaches reduce the dependence on structural insights while enabling the discovery of synergistic effects across mutations. Automation technologies, including robotic liquid handlers and integrated platforms, have become central to modern protein engineering by reducing errors, ensuring reproducibility, and enabling large-scale variant screening. Emerging autonomous platforms demonstrate closed-loop optimization that couples protein library design, automated plasmid transformation/protein expression and corresponding assays, and machine learning-driven decision-making. These systems achieve significant accelerations in the research process, reducing multi-round engineering cycles from months to days while successfully improving diverse proteins/enzymes to a targeted objective. Beyond single-lab platforms, orchestration frameworks adhering to FAIR data principles and leveraging knowledge graphs promise distributed 'self-driving' laboratories capable of coordinating workflows across facilities. While high setup costs and proprietary systems remain challenging, open-source and modular alternatives highlight a path toward transparent, flexible automation. Collectively, these innovations are redefining protein engineering as an increasingly autonomous, data-driven discipline.

Authors

Institutions

Publication Details

Journal
Current Opinion in Biotechnology
Published
2025-11-28
DOI
https://doi.org/10.1016/j.copbio.2025.103395
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advances and critical evaluation of autonomous protein engineering: towards transparent, accessible, and reproducible platforms

Uwe T. Bornscheuer, Katrin Weigmann, Mark Doerr
Current Opinion in Biotechnology
Monoclonal and Polyclonal Antibodies Research
article

Advances and critical evaluation of autonomous protein engineering: towards transparent, accessible, and reproducible platforms

Uwe T. Bornscheuer, Katrin Weigmann, Mark Doerr
article en

Abstract

Protein engineering aims to enhance enzymatic properties such as activity, selectivity, stability, and solvent tolerance by restructuring protein frameworks beyond natural performance limits. This process relies on the iterative Design-Build-Test-Learn cycle, where experimental feedback guides progressive improvements. Advancements in artificial intelligence have transformed both the Design and Learn phases, with zero-shot protein language models predicting beneficial mutations directly from sequence data and supervised models integrating assay results to refine subsequent variant designs. These approaches reduce the dependence on structural insights while enabling the discovery of synergistic effects across mutations. Automation technologies, including robotic liquid handlers and integrated platforms, have become central to modern protein engineering by reducing errors, ensuring reproducibility, and enabling large-scale variant screening. Emerging autonomous platforms demonstrate closed-loop optimization that couples protein library design, automated plasmid transformation/protein expression and corresponding assays, and machine learning-driven decision-making. These systems achieve significant accelerations in the research process, reducing multi-round engineering cycles from months to days while successfully improving diverse proteins/enzymes to a targeted objective. Beyond single-lab platforms, orchestration frameworks adhering to FAIR data principles and leveraging knowledge graphs promise distributed 'self-driving' laboratories capable of coordinating workflows across facilities. While high setup costs and proprietary systems remain challenging, open-source and modular alternatives highlight a path toward transparent, flexible automation. Collectively, these innovations are redefining protein engineering as an increasingly autonomous, data-driven discipline.

Current Opinion in BiotechnologyVol. 97
Universitätsmedizin Greifswald (DE), Universität Greifswald (DE)
Openalex Percentile: Top 48%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.